CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

The incidence of severe and very severe hot flashes decreased from 1.4 per day ... participants were notified of their treatment assignment and had the option of participating in an eight-week ...

A mom was diagnosed with a cancerous brain tumor and given a year to live after suffering from "strange" symptoms - including ...

Eric Morrow told his doctor about his family history of prostate cancer and asked if he needed testing. His doctor said no.

Ravi Parikh is a genitourinary medical oncologist at Winship Cancer Institute of Emory University. In the days since former ...

Others will go on to pursue treatment options. "Some people have very few symptoms ... Hormone therapy to treat especially troubling symptoms like severe hot flashes and crippling mood swings has been ...

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS) that affects daily life in the time ...